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Introduction
Proteinuria, in particular albuminuria, has long been
considered a marker of progression not only in renal,
but also in selected forms of cardiovascular disease.
Several studies in recent years have suggested that the
presence of proteins in the ultrafiltrate may be an inde-
pendent factor causing deterioration in kidney func-
tion. Hyperfiltration of albumin is followed by
increased reabsorption in the kidney proximal tubule
(1). Both animal and clinical studies have suggested
that protein and albumin itself can be toxic to the prox-
imal tubule epithelium causing interstitial inflamma-
tion and fibrosis (2–7). This implicates that tubular
uptake of albumin may be an important factor for the
development and progression of chronic renal disease.
Cubilin is a 460-kDa glycoprotein with no trans-
membrane domain (8). The receptor is heavily expressed
in the kidney proximal tubule brush border and intra-
cellular endocytic compartments (9). Cubilin binds to
the transmembrane, endocytic receptor megalin, and it
has been suggested that megalin is a coreceptor involved
in the endocytosis and intracellular trafficking of
cubilin (8). Cubilin is also the established intrinsic fac-
tor receptor involved in the intestinal uptake of the
intrinsic factor vitamin B12 complex (10, 11). Little or no
intrinsic factor (IF) is present in plasma, and although
cubilin recently was identified as a receptor for HDL
and apolipoprotein A-I (12, 13), the physiological sig-
nificance of cubilin within the kidney is not fully eluci-
dated. Recently, mutations in the cubilin gene have been
identified in patients suffering from Imerslund-Gräs-
beck syndrome, an inherited vitamin B12 deficiency dis-
ease characterized by vitamin B12 malabsorption (14).
These patients have varying degrees of proteinuria
resistant to vitamin B12 supplementation (15, 16). Fur-
thermore, an inherited vitamin B12 malabsorption syn-
drome in dogs characterized by abnormal processing
and the absence of apical cubilin in the intestinal and
renal epithelia cells is associated with proteinuria (17,
18). Our finding of heavy albuminuria in these animals
prompted us to study the significance of cubilin to nor-
mal tubular albumin reabsorption.
Using different biochemical and morphological
approaches, including affinity chromatography, sur-
face plasmon resonance (SPR) analysis, and immuno-
cytochemistry to analyze renal tissues and urine from
animal models of cubilin and megalin deficiency, we
have identified cubilin as an albumin binding protein
important to normal tubular albumin reabsorption.
On the basis of these data, we suggest a new and com-
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Using affinity chromatography and surface plasmon resonance analysis, we have identified cubilin,
a 460-kDa receptor heavily expressed in kidney proximal tubule epithelial cells, as an albumin bind-
ing protein. Dogs with a functional defect in cubilin excrete large amounts of albumin in combina-
tion with virtually abolished proximal tubule reabsorption, showing the critical role for cubilin in
the uptake of albumin by the proximal tubule. Also, by immunoblotting and immunocytochemistry
we show that previously identified low–molecular-weight renal albumin binding proteins are frag-
ments of cubilin. In addition, we find that mice lacking the endocytic receptor megalin show altered
urinary excretion, and reduced tubular reabsorption, of albumin. Because cubilin has been shown to
colocalize and interact with megalin, we propose a mechanism of albumin reabsorption mediated by
both of these proteins. This process may prove important for understanding interstitial renal inflam-
mation and fibrosis caused by proximal tubule uptake of an increased load of filtered albumin.
J. Clin. Invest. 105:1353–1361 (2000).
plex mechanism of albumin reabsorption involving
the two high–molecular-weight receptors, possibly
through inter-receptor interactions.
Methods
Renal tissues and urine. Rat kidney cortical membranes
were obtained from Wistar rats. The kidney cortex was
dissected from individual kidneys, minced, and
homogenized in 0.31 M sucrose, 15 mM HEPES, 8.5
m M leupeptin, 0.4 mM Pefabloc (pH 7.5) by five strokes
of a Potter-Elvehjem homogenizer at 1,250 rpm. The
homogenate was centrifuged at 4,000 g for 15 minutes,
rehomogenized, and the supernatants were pooled and
centrifuged at 200,000 g for 1 hour. The pellet repre-
senting crude membranes was solubilized overnight in
0.14 M NaCl, 2 mM CaCl2, 10 mM HEPES, 0.4 mM
Pefabloc, and 1% Triton X-100 (pH 7.4). The solubilized
membranes were recovered as the supernatant after
centrifugation at 30,000 g for 1 hour. All procedures
were carried out on ice or at 4°C.
A family of mixed-breed dogs originating from giant
schnauzer dogs exhibiting simple autosomal recessive
inheritance of selective cobalamin malabsorption has
previously been thoroughly characterized (17, 18). Bio-
chemical analyses revealed a decrease in IF-B12 binding
activity in both kidney homogenate (tenfold) and iso-
lated kidney cortical brush border membranes (180-
fold) supported by the absence of immunodetectable
cubilin in the brush border membrane fraction by
immunoblotting. Furthermore, the cubilin from affect-
ed dog kidney was shown to be largely endo-H sensitive
in contrast to cubilin from normal dogs (18). Thus,
these dogs exhibit abnormal processing and defective
insertion of cubilin into the luminal plasma mem-
branes of cubilin expressing cells, causing failure of
intestinal absorption of IF-B12 and selective proteinuria
resembling the Imerslund-Gräsbeck disease in humans
(17). All affected dogs were treated regularly with par-
enteral vitamin B12 and were in hematologic and meta-
bolic remission. Urine samples were collected from six
affected and six normal dogs of various strains, age, and
sex. For immunocytochemistry, kidneys from three
affected and three normal dogs were analyzed. Megalin-
deficient mice were produced by gene targeting as
described elsewhere (19), and littermates were used as
controls. Urine was collected during a 6- to 24-hour
period. Mouse kidneys were fixed by perfusion through
the left ventricle of the heart; rat kidneys were fixed by
retrograde perfusion through the abdominal aorta; and
dog kidneys were fixed by perfusion through the renal
arteries. The fixative used was 1–4% paraformaldehyde
in 0.1 M sodium cacodylate buffer (pH 7.4).
Albumin affinity purification of cubilin. Rat serum albu-
min (RSA; 10 mg/mL; Sigma Chemical Co., St. Louis,
Missouri, USA) was coupled to CNBr-activated
Sepharose (Amersham Pharmacia Biotech AB, Uppsala,
Sweden) using 0.1 M NaHCO3 and 0.5 M NaCl (pH 8.3)
coupling buffer according to the protocol provided by
the manufacturer. Unreacted active sites were blocked
with 0.2 M glycine buffer (pH 8.0) followed by repeat-
ed alternating washes with 0.1 M NaC2H3O2 and 0.5 M
NaCl (pH 4.0) or the coupling buffer. A final volume of
5 mL gel was prepared. The solubilized rat kidney cor-
tical membranes were recirculated over the column
overnight at 0.2 mL/min. The column was extensively
washed in 20 mM Tris and 0.15 M NaCl (pH 7.4) fol-
lowed by elution of cubilin with 20 mM Tris, 0.15 M
NaCl, and 6 M urea (pH 7.4). Fractions (1 mL) were col-
lected, subjected to SDS-PAGE, and stained by
Coomassie blue. Additional gels were blotted onto
nitrocellulose membranes for further protein identifi-
cation by immunoblotting.
SPR analysis. For the SPR analyses, the BIAcore sensor
chips (type CM5; Biacore AB, Uppsala, Sweden) were
activated with a 1:1 mixture of 0.2 M N-ethyl-N ¢ -(3-
dimethylaminopropyl) carbodiimide and 0.05 M N-
hydroxysuccinimide in water according to the manu-
facturer’s directions. Rat cubilin purified by IF-B12
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Figure 1
Albumin affinity purification of
cubilin. (a) Eluted fractions were ana-
lyzed by SDS-PAGE and Coomassie
stained. Lane 1: 0.1 m g of RAP affinity
purified rabbit megalin; lane 2: IF-B12
affinity purified cubilin. Lanes 3–11:
fractions 4–12 (12 m L/lane). The posi-
tions of standard molecular weight
markers are indicated. A strong band
corresponding to the size of cubilin is
clearly identified in fractions 5–8. Faint
low–molecular-weight bands are seen
with both the IF-B12 purified and albu-
min purified cubilin. (b) The eluted
protein was further identified as
cubilin by immunoblotting using anti-
rat cubilin antibodies.
affinity chromatography was immobilized as described
elsewhere (11). The SPR signal from immobilized
cubilin generated BIAcore response units (RUs) equiva-
lent to 25–35 fmol/mm2. The flow cells were regenerat-
ed with 20 m L and 1.5 M glycine-HCl (pH 3.0). The flow
buffer was 10 mM HEPES, 0.15 M NaCl, 1.5 mM CaCl2,
and 1 mM EGTA (pH 7.4). The Kd for binding was esti-
mated using a BIAevaluation program (Biacore AB).
Receptors, ligands, and antibodies. Cubilin was purified
from rat kidney cortical membranes by IF-B12 affinity
chromatography of renal cortical membranes accord-
ing to the procedure described elsewhere (11). Rat albu-
min was obtained commercially as fraction V powder
and as globulin and/or fatty acid free, lyophilized pow-
der (Sigma Chemical Co.). Glycated or palmitylated
albumin was prepared from globulin and fatty acid free
rat albumin according to protocols described by others
previously (20, 21). In short, for glycation, 2 mg of rat
albumin was dissolved in 60 m L of 0.5 M glucose, 33
mM PBS, and 15 mM NaN3, and was incubated for 24
hours at 37°C giving an approximately 3:1 ratio of glu-
cose/albumin. This was followed by dialysis against 10
mM HEPES, 0.14 M NaCl, and 2 mM CaCl2 (pH 7.4)
for 24 hours at 5°C. For palmitylation, 2.8 m L of a 90
mM solution of palmitic acid in ethanol was added to
138 m L of rat albumin solution (300 m M) under stir-
ring. The solution was lyophilized and dissolved in 10
mM HEPES, 0.14 M NaCl, and 2 mM CaCl2 (pH 7.4)
before use. Samples of possible low–molecular-weight
albumin binding proteins was generated by Cessac-
Guillemet et al. as described previously (22).
The following polyclonal antibodies were used for
RIA, immunoblotting, and immunocytochemistry:
rabbit anti-rat cubilin antibodies raised against
immunopurified protein (23); rabbit anti-dog cubilin
(18); rabbit anti-albumin binding protein raised
against affinity purified albumin binding proteins as
described elsewhere (22); rabbit anti-dog albumin
(Organon Teknika Corp., Boxtel, The Netherlands);
rabbit anti-rat albumin (Nordic Immunological,
Tilbury, The Netherlands); sheep anti-rat albumin (Bio-
genesis, Poole, United Kingdom); and sheep anti-
mouse albumin (The Binding Site, Birmingham, Unit-
ed Kingdom). A mouse monoclonal anti-rat cubilin
antibody (75; ref. 24) and a sheep anti-megalin (25) was
used for triple labeling immunocytochemistry. The sec-
ondary antibodies used were horseradish peroxi-
dase–conjugated (HRP-conjugated) goat anti-rabbit,
goat anti-mouse, and rabbit anti-sheep immunoglob-
ulins (DAKO A/S, Glostrup, Denmark), and colloidal
gold coupled goat anti-rabbit, goat anti-mouse, and
donkey anti-sheep immunoglobulins (British BioCell
International, Cardiff, United Kingdom).
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Figure 2
SPR sensorgram of the binding of rat albumin to purified rat cubilin
immobilized to a BIAcore sensor chip. The BIAevaluation software esti-
mated Kd = 0.63 m M when fitting the curves to a one-site model. The
on and off rates for binding of rat albumin were recorded by a flow of
5 m M albumin followed by flow of buffer alone. The SPR signal is dis-
played as the mass-equivalent RUs.
Figure 3
Localization of cubilin (a and b)
and megalin (c and d) in kidney
cortex of normal (a and c) and
affected (b and d) dogs. Sections
were incubated with anti-dog
cubilin (1:4,000). In normal dogs,
cubilin is localized in luminal plas-
ma membranes of kidney proximal
tubules (a), whereas the labeling in
affected dogs is intracellular and
vesicular with no detectable recep-
tor in the luminal plasma mem-
brane (b), suggesting retention in
an intracellular compartment. No
difference in the labeling intensity
or in the distribution of megalin is
observed between normal (c) and
affected (d) dogs when evaluated
by immunocytochemistry using a
sheep anti-rat megalin (1:10,000).
· 600 (a and b); · 350 (c and d).
10 mM PBS, 0.15 M NaCl, 0.1% nonfat milk, and 20
mM NaN3, followed by incubation for 1 hour with
HRP-conjugated secondary antibody and visualization
by incubation with diaminobenzidine and 0.03% H2O2
for 10 minutes. Preincubation experiments were per-
formed by mixing anti-rat albumin binding protein
antibody with excess rat cubilin purified by IF-B12 affin-
ity chromatography before the incubation with sec-
tions. All incubations were performed at room temper-
ature, and sections were counterstained with Mayers
hematoxylin stain before examination in a Leica DMR
microscope equipped with a Sony SCCD color video
camera and a Sony Digital Still recorder (Sony Corp.,
Tokyo, Japan). Electron microscope immunocytochem-
istry was performed on ultrathin (90 nm) cryosections
incubated overnight at 5°C with primary antibodies
diluted 1:2,500–1:200,000 followed by incubation with
gold conjugated secondary antibodies in 50 mM Tris
buffer, 0.15 M NaCl, 0.1% BSA, 0.06% PEG, 1% fish gela-
tine, and 20 mM NaN3 for 2 hours at room tempera-
ture. Sections were photographed in a Phillips CM100
or EM208 electron microscope (Phillips, Eindhoven,
The Netherlands). Controls involving incubation with-
out primary antibody or incubation with nonspecific
mouse immunoglobulins or rabbit or sheep serum
revealed no significant labeling.
Results
Cubilin is an albumin binding protein. Cubilin was identi-
fied as an albumin binding protein by affinity chro-
matography. When rat cortical membranes were
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Figure 4
Increased urinary excretion and
decreased tubular reabsorption of
albumin in affected dogs. (a) Dogs
with a functional defect in cubilin
expression (n = 6) reveals a signifi-
cant, approximately sevenfold
increase (P = 0.00003) in urinary
albumin/creatinine excretion com-
pared with normal control dogs (n =
6). (b and c) Immunohistochemistry
using an anti-dog albumin antibody
(1:100,000) to identify albumin in
the kidney cortex of normal (b) and
affected (c) dogs. In normal dogs (b),
evidence of reabsorbed and endocy-
tosed albumin in proximal tubules is
clear (arrows), whereas no albumin
can be identified inside the proximal
tubules of affected dogs (c). In all
dogs, a faint labeling was observed in
basement membranes due to a basal
deposition of albumin. · 600. Three
affected and three normal dogs were
examined using two different anti-
albumin antibodies, all showing the
same labeling pattern. (d) Electron microscopic immunocytochemistry using anti-dog
albumin antibody (1:5,000) on a section of normal dog proximal tubule cells. Intense
labeling of four lysosomes and part of a fifth is observed corresponding to the vesicular
labeling observed with light microscopic immunohistochemistry. · 33,000.
Determination of urinary albumin excretion by RIA. Dog or
mouse urine samples were incubated with polyclonal anti-
bodies against dog (1:10–1:500) or rat albumin (1:10, cross-
reacting fully with mouse serum albumin). After 48 hours’
incubation, polyethylene glycol was used for separation of
free and antibody-bound iodinated albumin as described
previously (26). Dog or rat albumin (Sigma Chemical Co.)
was used for iodination and calibration. Albumin excretion
both in dogs and mice was related to creatinine excretion
measured by standard procedure. Data was compared using
the Student’s t test.
SDS-PAGE and immunoblotting. Samples of membrane frac-
tions or urine proteins were subjected to SDS-PAGE using
polyacrylamide minigels (Bio-Rad Mini Protean II; Bio-Rad
Laboratories Inc., Hercules, California, USA), and transferred
to nitrocellulose membranes. Blots were blocked with 5%
nonfat milk in PBS-T (80 mM Na2HPO4, 20 mM NaH2PO4,
0.1 M NaCl, and 0.1% Tween 20 [pH 7.5]) for 1 hour, and
incubated overnight at 4°C with primary antibody in PBS-T
with 1% BSA. After washing in PBS-T, the blots were incu-
bated for 1 hour with HRP-conjugated secondary antibody
diluted 1:3,000. After final wash, antibody binding was visu-
alized using the ECL enhanced chemiluminescence system
(Amersham Pharmacia Biotech AB). Controls involving incu-
bation without primary antibody and incubation with non-
specific serum revealed no significant labeling.
Immunocytochemistry. For light microscope immunocyto-
chemistry, semithin cryosections were cut on a Reichert
Ultracut S (Reichert-Jung, Vienna, Austria) and placed on
gelatine-coated glass slides. Sections were incubated 1 hour
with the primary antibody diluted 1:3,000 to 1:200,000 in
applied to a column of rat albumin, significant
amounts of an approximately 460-kDa protein were
recovered. This protein could be identified as cubilin by
immunoblotting using antibodies raised against
immunopurified rat cubilin (Figure 1). SPR analysis
confirmed binding of albumin to purified and immo-
bilized cubilin (Figure 2). Using the BIAevaluation pro-
gram, Kd was estimated to 0.63 m M. A slightly lower
binding affinity was found for palmitylated albumin,
whereas no difference was observed with fatty acid free
or glycated albumin (data not shown).
Cubilin is important to normal albumin reabsorption. To
establish the physiological significance of cubilin to
renal tubular albumin reabsorption, we examined dogs
exhibiting an inherited defect in cubilin expression.
Biochemical studies have shown abnormal processing
and defective insertion of cubilin into the luminal plas-
ma membranes of affected dogs (18). We confirmed
this by immunocytochemistry. In contrast to the lumi-
nal localization in normal dog proximal tubules, the
affected dogs revealed an intracellular, vesicular label-
ing with no detectable receptor in the luminal plasma
membrane (Figure 3, a and b). No difference was
observed in the labeling intensity or in the distribution
of megalin (Figure 3, c and d), showing that this recep-
tor is normally expressed in the affected dogs.
A significant albuminuria reflected by an approxi-
mately sevenfold increase in urinary albumin/creati-
nine excretion ratio (Figure 4a) was observed in six
dogs with defective cubilin expression compared with
six normal control dogs (P = 0.00003). To evaluate the
origin of this albuminuria, we analyzed tubular albu-
min reabsorption by immunohistochemistry. In nor-
mal dogs, efficient tubular reabsorption was reflected
by intense intracellular labeling for albumin in kidney
proximal tubule cells (Figure 4b). Labeling appeared
vesicular, and electron microscope immunocytochem-
istry revealed labeling of the endocytic apparatus, in
particular lysosomes reflecting the accumulation of
endocytosed albumin in this compartment (Figure
4d). In affected dogs, no intracellular labeling was
observed in the renal tubules (Figure 4c), suggesting
defective internalization. Thus, the functional defect
in luminal cubilin expression is associated with
decreased proximal tubule albumin endocytosis and
increased urinary albumin excretion.
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Figure 5
Immunological cross-reaction and colocalization of antibodies raised against cubilin and antibodies against previously identified albumin
binding proteins (ABP). (a) Immunoblotting using polyclonal anti-ABP antibody on affinity purified rat cubilin and rat kidney cortex. Both
the IF-B12 and albumin affinity purified cubilin, as well as a similar band in rat kidney cortex, were recognized by the anti-ABP. (b and c) Flu-
orescent double labeling reveals identical labeling using rabbit anti-ABP (1:3,000) and monoclonal mouse anti-cubilin (1:5,000) on the
same section of rat cortex followed by secondary TRITC labeled anti-rabbit IgG (red fluorescent in b) and FITC-labeled anti-mouse IgG (green
fluorescent in c). The antibodies colocalize along the brush border and apical cytoplasm, as well as in vesicular structures in the proximal
tubules. (d and e) Inhibition of labeling with anti-ABP by preincubation with IF-B12 affinity purified cubilin. Immunocytochemical labeling
using anti-ABP (1:8,000) on cryosections of kidney cortex reveals proximal tubule apical labeling (d) that is clearly inhibited when the anti-
ABP is preincubated with affinity purified cubilin (e). · 700.
Immunological similarity between cubilin and previously
identified low–molecular-weight albumin binding proteins.
Antibodies raised against previously described albu-
min binding proteins of 31 and 55 kDa (22) reacted
against cubilin purified on both IF-B12 and albumin
affinity columns (Figure 5a). The apical expression of
these proteins in the kidney proximal tubule cells as
revealed by immunohistochemistry using an antibody
against the low–molecular-weight albumin binding
proteins was very similar to that of cubilin identified
by anti-cubilin antibodies (Figure 5, b and c). Further-
more, the labeling by the antibody against the
low–molecular-weight albumin binding proteins
could be strongly inhibited by preincubation with IF-
B12 affinity purified cubilin (Figure 5, d and e). Final-
ly, immunoblotting using the anti-cubilin antibody on
the albumin binding protein samples purified by Ces-
sac-Guillemet et al. (22) revealed the same low–molec-
ular-weight bands as identified by the antibody against
the low–molecular-weight albumin binding proteins,
suggesting that these protein bands represent frag-
ments of cubilin (data not shown).
Megalin is involved in albumin reabsorption. An approxi-
mately threefold increase in albumin/creatinine excre-
tion ratio was observed in five megalin-deficient mice
compared with five wild-type mice (31 ± 12 vs. 11 ± 6
m g/mg). Although not statistically significant (P =
0.17), the observation is in accordance with decreased
tubular albumin reabsorption. Owing to the poor via-
bility of megalin-deficient mice (19), we were unable to
collect urine from more than five megalin-knockout
mice. Tubular albumin reabsorption in megalin-defi-
cient and control mice was further evaluated by
immunohistochemistry identifying internalized albu-
min in kidney tubules. In normal mice, albumin could
be identified as a vesicular labeling in proximal tubules,
whereas no albumin was detected in proximal tubules
from megalin-deficient mice (Figure 6). These findings
were consistent when analyzing four different knock-
out and five corresponding wild-type or heterozygous,
normal mice. Thus, albumin reabsorption was strong-
ly inhibited in megalin-knockout mice.
The involvement of both cubilin and megalin in
albumin reabsorption was supported by the colocal-
ization of endogenous albumin, megalin, and cubilin
in endocytic compartments of proximal tubule cells as
demonstrated by electron microscope immunocyto-
chemistry (Figure 7). Cubilin and megalin colocalized
on the luminal membrane, in endocytic compart-
ments, and in the recycling compartment dense apical
tubules. Albumin was found in similar compartments,
however concentrating in late endosomes and lyso-
somes, suggesting that most of the endocytosed ligand
is internalized for degradation, whereas the receptors
recycle to the luminal membrane.
Discussion
The present data demonstrate the involvement of
cubilin in kidney proximal tubule albumin reabsorp-
tion. Cubilin binds to albumin during affinity chro-
matography and binding is confirmed by SPR analysis.
Furthermore, dogs with an abnormal processing and
defective insertion of cubilin into the luminal mem-
branes (Figure 1) causing a defect in intestinal absorp-
tion of IF-B12 and proteinuria display significant albu-
minuria and decreased tubular uptake of albumin. The
clinically related Imerslund-Gräsbeck disease is also
associated with various degrees of albuminuria
(approximately two thirds of total urinary protein)
(27). Recently, two independent mutations in the
cubilin gene was identified in 17 Finnish families suf-
fering from this disease (14), indicating a heterogene-
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Figure 6
Decreased tubular reabsorption of albu-
min in megalin-deficient mice. (a and b)
Immunohistochemistry using an anti-
mouse albumin antibody (1:3,000) to
identify albumin in the kidney cortex of
normal (a) and megalin-deficient (b)
mice. In normal mice (a), evidence of
reabsorbed and endocytosed albumin in
proximal tubules is clear (arrows), where-
as no albumin can be identified inside
the proximal tubules of megalin-deficient
mice (b). · 1,000. Four megalin-deficient
and five normal mice were examined,
showing the same difference in labeling
pattern. (c and d) Immunocytochemical
localization of cubilin using an anti-dog
cubilin antibody (1:200) in normal (c)
and megalin-deficient (d) mice. Cubilin is
expressed and normally distributed in the
megalin-deficient mice (d) when com-
pared with controls (c); however, the
labeling intensity is reduced. · 600.
ity of mutations that is likely to explain some of the dif-
ferences in protein and albuminuria observed in Imer-
slund-Gräsbeck patients (15, 27).
The Kd of albumin binding to cubilin estimated by
SPR analysis is 0.63 m M. This is in accordance with pre-
viously described affinities for albumin binding to iso-
lated proximal tubule segments and cultured opossum
kidney cells (28–31). Most studies identified both high-
and low-affinity binding sites with affinities ranging
0.3–2.0 and 18–240 m M, respectively (30, 31). Whereas
the affinity for albumin binding to cubilin demon-
strated here compares to the previously described high-
affinity albumin binding sites, the affinity for albumin
binding is low compared with the other known ligands
for cubilin, i.e., IF (11) and apolipoprotein A-1 (13). A
relatively low affinity of albumin reabsorption explains
why increases in the load of filtered albumin lead to
increases in urinary albumin excretion rates (32), and
why the uptake of native albumin is significantly
reduced when microinjected into late parts of the prox-
imal convoluted tubule (33).
Cubilin is also heavily expressed the yolk sac epithe-
lia (34). In early gestation of rodents, the yolk sac serves
an important function for embryonic development as
the major source of amino acids after the uptake and
degradation of maternal protein (35). Because albumin
constitutes the major plasma protein, it can be specu-
lated that cubilin is important for the delivery of amino
acids in the early embryonic period of rodents.
Several putative albumin binding proteins have been
described in endothelial cells including 18-, 30-, and
60-kDa glycoproteins (36–38). Receptors of similar
molecular weight were purified from kidney cortex by
albumin affinity chromatography and identified by
immunoblotting and immunocytochemistry (22). The
present study shows strong cross reactivity between
antibodies raised against these low–molecular-weight
binding proteins and cubilin in addition to a very sim-
ilar cellular distribution in the proximal tubule cells.
Furthermore, the anti-cubilin antibody identified the
same low–molecular-weight protein bands as the anti-
body raised by Cessac-Guillemet et al. (22), strongly
indicating that these low–molecular-weight proteins
are in fact fragments of cubilin. When performing
albumin affinity chromatography similar to the pro-
tocol described by Cessac-Guillemet et al. (22), we were
able to purify significant amounts of cubilin, which
however, were not identified in their study. This may
be explained by their use of 12% polyacrylamide sepa-
rating gels to identify purified proteins, not allowing
the migration of high–molecular-weight proteins such
as cubilin. Electrophoresis of both IF-B12 and albumin
purified cubilin also revealed very faint low–molecu-
lar-weight protein bands. Most likely these are frag-
ments of cubilin. The bands are of varying molecular
weight and have been observed previously when puri-
fying cubilin by IF-B12 or RAP affinity chromatogra-
phy (11). The present study does not exclude the pres-
ence of other albumin binding proteins, particularly
The Journal of Clinical Investigation | May 2000 | Volume 105 | Number 10 1359
Figure 7
Colocalization of endogenous albumin, cubilin, and megalin in endo-
cytic compartments of normal rat proximal tubules. Section of rat kid-
ney proximal tubule incubated with rabbit anti-rat albumin (1:10,000),
sheep anti-rat megalin (1:50,000), and monoclonal mouse anti-rat
cubilin (1:2,500) followed by incubation with gold conjugated goat anti-
rabbit immunoglobulins (10 nm), donkey anti-sheep immunoglobulins
(15 nm), and goat anti-mouse immunoglobulins (5 nm). Megalin (15-
nm gold particles; arrows) and cubilin (5-nm gold particles; large arrow-
heads) colocalize (a) at the brush border (BB) and in endocytic vesicles
(E) as well as in the recycling compartment dense apical tubules (D).
Albumin (10-nm gold particles; small arrowheads) colocalize with the
receptors in endocytic invaginations (I) and vesicles (E) and is concen-
trated in later endocytic compartments and lysosomes containing only
little labeling for the receptors (b). Notice that most tubular structures
(D) contain only labeling for the receptors supporting efficient recycling
of these in contrast to albumin, which is degraded (b). · 58,000.
in other cell types and possibly serving different phys-
iological functions. A different affinity for modified
albumin has been described for the 18- and 30-kDa
binding proteins, suggesting that these are involved in
the clearance of conformationally modified albumin
(36). Because there is no evidence that only modified
albumin is filtered in the glomeruli, it appears reason-
able that receptors involved in tubular uptake would
bind different forms of albumin with similar affinity,
as is the case with binding of palmitylated or glycated
albumin to cubilin.
The present study also supports a role for the mul-
tiligand, endocytic receptor megalin (9, 39) in tubular
albumin uptake by showing decreased tubular albu-
min uptake and possibly increased urinary albumin
excretion in megalin-deficient mice. These mice
express cubilin apically as shown by immunocyto-
chemistry. The difference in urinary albumin excre-
tion between megalin-deficient and wild-type mice
was less than the difference observed between affect-
ed and normal dogs. The average albumin/creatinine
excretion ratio was 11 ± 6 m g/mg in normal mice com-
pared with 1.2 ± 0.3 m g/mg in normal dogs. Assuming
that the normal amount of albumin filtered is pro-
portional to the creatinine excretion, this may suggest
that the reabsorption of albumin in the mice is less
efficient than in the dogs. Thus, a defective albumin
reabsorption in the mice may result in a smaller rela-
tive increase in urinary albumin excretion when com-
pared with the dogs. Megalin may be involved in
tubular albumin reabsorption in at least two different
ways. First, a previous study suggested that megalin
was able to bind and mediate the endocytosis of albu-
min in kidney proximal tubules in vivo (40). Second,
it was recently shown by megalin affinity chromatog-
raphy and SPR analysis that cubilin binds with high
affinity to megalin, and it was hypothesized that
megalin mediates the endocytosis and intracellular
trafficking of cubilin (8). This suggests an additional,
indirect role of megalin in the reabsorption of albu-
min involving the binding of albumin to cubilin fol-
lowed by megalin mediated endocytosis of the
cubilin-albumin complex. The present finding of
colocalization between endogenous albumin, cubilin,
and megalin in endocytic compartments of rat proxi-
mal tubule cells supports this notion.
In conclusion, the present study shows that cubilin
constitutes an albumin binding protein important for
normal proximal tubule reabsorption of albumin.
However, both cubilin and megalin deficiency is asso-
ciated with decreased albumin uptake in the proximal
tubule. Thus, a mechanism for reabsorption involving
both receptors is suggested. Because excessive proxi-
mal tubule albumin uptake, under conditions of
increased glomerular filtration of proteins, may con-
tribute to the progression of renal disease, this mech-
anism may prove important to the understanding of
renal pathophysiology and for establishing new strate-
gies to prevent renal deterioration.
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